BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
4.800
+0.060 (1.27%)
At close: Aug 28, 2025, 4:00 PM
4.800
0.00 (0.00%)
After-hours: Aug 28, 2025, 4:00 PM EDT
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $171.72 million as of August 28, 2025.
Market Cap
171.72M
Enterprise Value
-134.73M
1-Year Change
n/a
Ranking
Category
Stock Price
4.80
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $171.72M, a decrease of -72.08%. That is a compound annual growth rate of -75.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 169.93M | -18.13% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.09B |
| Johnson & Johnson | 425.77B |
| AbbVie | 367.55B |
| UnitedHealth Group | 275.22B |
| AstraZeneca | 248.07B |
| Novo Nordisk | 246.45B |
| Novartis AG | 245.68B |
| Abbott Laboratories | 228.80B |